Auvi
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2886 N Nohl Canyon Rd, Orange, Californi...Website
www.auvi-q.comRevenue
$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Auvi
AUVI-Q offers epinephrine injections aimed at patients experiencing anaphylaxis. Their products are targeted at healthcare professionals and the general public. The company also provides resources, safety information, and prescribing guidance to ensure proper usage. Additionally, they offer training sessions to educate users about anaphylaxis management.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Auvi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Auvi has recently received funding, and reach out quickly before it becomes old news!
Click to see if Auvi had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Auvi has new funding data
Check out if Auvi is spiking on competitors!
Product Launch: Get notified when Auvi launches new products
Congratulate Masked Content for being promoted to Masked Content at Auvi
Earning: See what the market has to say on Auvi recently announced quarterly report
Auvi, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Auvi as Masked Content
Find 3 more new buyers
Compare Similar Companies to Auvi
Compare insights from companies similar to Auvi, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Auvi
$5M
11-50
Private
-
2008
N/A
Company Profile Activity
Activity Insights
Auvi is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Auvi is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Auvi.
Auvi Tech Stack
A closer look at the technologies used by Auvi
Auvi News & Media
Kaleo’s AUVI-Q® (epinephrine injection, USP) Selected by Axiom Space to Help Protect Crew from Allergic Emergencies
Richmond, Virginia, July 24, 2025 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injector innovation, today announced that AUVI-Q® (epinephrine injection, USP) was cleared for use as a part of Axiom Mission 4 that took flight on June 25, 2025, and returned on July 15, 2025. AUVI-Q was selected by Axiom Space to support Axiom Space crew members in the event of an allergic emergency.Retrospective Analysis of U.S. Claims Data Shows AUVI-Q® (epinephrine injection, USP) Prescription Associated with Lower Rates of Anaphylaxis-Related Inpatient Hospitalizations Compared to Other Epinephrine Auto-Injectors
Richmond, Virginia, May 15, 2025 (GLOBE NEWSWIRE) -- New findings from a retrospective analysis of U.S. commercial claims data indicate that patients prescribed AUVI-Q® (epinephrine injection, USP) experienced lower rates of inpatient hospitalization for anaphylaxis compared to patients prescribed other epinephrine auto-injectors (EAIs). The results are being presented during the ISPOR 2025 North America Conference, May 13–16, 2025, in Montreal, Quebec, Canada.Kaléo Redesigns Commercial Team to Increase Support for AUVI-Q® (epinephrine injection, USP)
Richmond, Virginia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Kaléo, a privately-held U.S. pharmaceutical company has announced a redesign of the AUVI-Q® (epinephrine injection, USP) commercial team structure to increase in-office support for healthcare providers. AUVI-Q is a prescription medicine used to treat emergency allergic reactions, including anaphylaxis, in people who are at risk for or who have a history of serious allergic reactions.Walgreens and Kaléo Expand Retail Pharmacy Collaboration to Include AUVI-q® (epinephrine injection, USP) 0.1 mg, the Only FDA-Approved Epinephrine Auto-Injector for Infants and Toddlers, 16.5 – 33 lbs
DEERFIELD, Ill. & RICHMOND, Va.--(BUSINESS WIRE)--Walgreens and kaléo, a privately-held pharmaceutical company, today announced AUVI-q® (epinephrine injection, USP) 0.1 mg auto-injector is available at Walgreens locations nationwide. AUVI-q 0.1 mg is the first and only epinephrine auto-injector (EAI) approved by the U.S. Food and Drug Administration (FDA) for infants and toddlers weighing 16.5 to 33 pounds (7.5 to 15 kilograms). Through this collaboration, Walgreens is the first national ret
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Auvi
Sign Up For FreeTo access detailed company insights
AUVI-Q offers epinephrine injections aimed at patients experiencing anaphylaxis. Their products are targeted at healthcare professionals and the general public. The company also provides resources, safety information, and prescribing guidance to ensure proper usage. Additionally, they offer training sessions to educate users about anaphylaxis manag... Read More
